Population Health Management and Data Analytics
Most companies waste between 35%-65% of their medical spending each year. Unfortunately, it can be almost impossible for an organization to identify and implement the right strategies that decrease spending, while still providing a rich benefits plan. Alera Group’s dedicated team of population health management and data analytics experts have the right tools and in-house expertise to conduct a deep analysis of your data organization's data. Our team can help you implement the right strategies and benefits plan to contain health spending, while meeting the diverse needs of your population. Our experts will:
- Integrate data by plan member into a comprehensive view of the entire organization’s population
- Leverage the right data to make long-term strategic plan decisions that help control healthcare costs
- Implement data modeling to identify opportunities to incentivize employee behavior to impact health spending
- Evaluate employee data, such as risk categories that impact health costs and strategies
- Analyze high-risk populations to implement strategic solutions that lead to targeted savings
- Utilize comparison modeling to compare providers and select the best provider and plan for your organization.
Our team will work with you to identify cost drivers and implement strategies that empower healthier employees and a more profitable organization.
Population Health Information
Insights You Need to Control Benefits Spending.
EXPERT EDUCATION
Events and Webinars
Employee Benefits
Setting Your Strategy for the New Year: Alera Group's 2025 Employee Benefits Market Outlook
Our experts will highlight key results from Alera Group’s "2025 Employee Benefits Market Outlook" and explain how these trends can impact your benefits program this year.
January 16, 2025 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
The Value of Voluntary Benefits
In this session, our experts will showcase the value of voluntary benefits, from financial savings to improved retention to addressing the specific needs of their employees.
March 20, 2025 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Dynamic Data: Strategies for Success
Join us for this session, as our experts will share how to utilize your organization’s data to create advanced and innovative strategies for success.
July 17, 2025 at 01:00 pm CT | Virtual
Sign Up
THOUGHT LEADERSHIP
Insights
Employee Benefits
Don’t Forget About Your Gag Clause Attestations
When the Consolidated Appropriations Act, 2021 (CAA) was enacted on December 27, 2020, it included a provision that prohibits group health plans and health insurance carriers from entering into certain agreements that, either directly or indirectly, restrict the release of certain information related to provider networks and de-identified encounter data, among other things. Such restrictions are commonly referred to as “gag clauses.” The CAA also requires plans and carriers to attest annually that their agreements do not include such impermissible gag clauses.
November 20, 2024
Find out more
Employee Benefits
Avoiding an Employee Lawsuit Over a Tobacco Surcharge Claim
Tobacco surcharges on health insurance premiums for employees who use tobacco products are attractive options for employers looking to keep their workforce healthy while lowering their organization’s healthcare costs. But surcharges can go too far, and many employers may be unaware of the limitations. Alera Group's new whitepaper on tobacco surcharges is designed to assist employers in complying with federal regulations.
November 19, 2024
Find out more Employee Benefits
How To Lower Healthcare Costs While Improving Benefit Offerings
Join us on June 20 for a one-hour webinar designed to help you eliminate wasteful healthcare spending while providing your employees with benefits that attract and retain talent. We’ll take you through our three-step solution.
June 11, 2024
Find out more Employee Benefits
Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group
Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.
February 6, 2024
Find out more